Princeton Capital Management LLC Amgen Inc Transaction History

Princeton Capital Management LLC

$302 Million
Q2 2024

A detailed history of Princeton Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Princeton Capital Management LLC holds 8,731 shares of AMGN stock, worth $2.76 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

8,731

Previous 9,209 5.19%

Holding current value

$2.76 Million

Previous $2.62 Million 4.2%

% of portfolio

0.9%

Previous 0.96%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$262.75 - $319.31 $125,594 - $152,630	-478 Reduced 5.19%	8,731 $2.73 Million
Q1 2024 May 09, 2024	BUY	$268.87 - $324.56 $52,698 - $63,613	196 Added 2.17%	9,209 $2.62 Million
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $19,177 - $21,634	-75 Reduced 0.83%	9,013 $2.6 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $195,691 - $242,956	-895 Reduced 8.97%	9,088 $2.44 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $8,142 - $9,628	-38 Reduced 0.38%	9,983 $2.22 Million
Q1 2023 May 01, 2023	BUY	$225.79 - $275.2 $83,542 - $101,824	370 Added 3.83%	10,021 $2.42 Million
Q4 2022 Jan 31, 2023	BUY	$229.03 - $291.01 $802,063 - $1.02 Million	3,502 Added 56.95%	9,651 $2.53 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $15,038 - $16,961	67 Added 1.1%	6,149 $1.39 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $8,074 - $8,985	-35 Reduced 0.57%	6,082 $1.48 Million
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $19,295 - $21,346	-88 Reduced 1.42%	6,117 $1.48 Million
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $397 - $455	2 Added 0.03%	6,205 $1.4 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $21,956 - $24,359	94 Added 1.54%	6,203 $1.51 Million
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $4,882 - $5,689	22 Added 0.36%	6,109 $1.52 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $113,815 - $135,534	526 Added 9.46%	6,087 $1.4 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $97,379 - $108,294	415 Added 8.06%	5,561 $1.41 Million
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $29,705 - $39,397	163 Added 3.27%	5,146 $1.22 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $12,677 - $16,294	-67 Reduced 1.33%	4,983 $1.14 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $4,700 - $5,632	27 Added 0.54%	5,050 $977,000
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $340,734 - $399,418	2,044 Added 68.61%	5,023 $926,000
Q1 2019 May 02, 2019	BUY	$180.87 - $203.88 $442,227 - $498,486	2,445 Added 457.87%	2,979 $566,000
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $84,740 - $98,918	475 Added 805.08%	534 $104,000
Q3 2018 Nov 08, 2018	SELL	$185.29 - $208.89 $8,708 - $9,817	-47 Reduced 44.34%	59 $12,000
Q1 2018 May 03, 2018	BUY	$169.43 - $198.0 $17,959 - $20,988	106 New	106 $18,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Capital Management LLC with notifications on news.

Account

Princeton Capital Management LLC Amgen Inc Transaction History